Position history for Assenagon Asset Management S.A.'s holdings in VERTEX PHARMACEUTICALS INC
Assenagon Asset Management S.A. holds 832,853 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $377.6M as of 2025-Q4. The position was increased (++9.1% shares). VRTX represents 0.5% of Assenagon Asset Management S.A.'s portfolio.
Current Value
$377.6M
Current Shares
832,853
Total Value Change
+$332.5M
Total Shares Change
+736,658
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 832,853 |
+9.1% |
| $377.6M |
| 0.5% |
| $453.74 |
48 |
| 2025-Q3 | Increased | 763,703 | +214.6% | $299.1M | 0.4% | $395.31 | 60 |
| 2025-Q2 | Increased | 242,754 | +16.6% | $108.1M | 0.2% | $441.30 | 42 |
| 2025-Q1 | Decreased | 208,140 | -75.2% | $100.9M | 0.2% | $492.69 | 0 |
| 2024-Q4 | Increased | 839,672 | +169.4% | $338.1M | 0.5% | $399.35 | 71 |
| 2024-Q3 | Increased | 311,643 | +224.0% | $144.9M | 0.3% | $462.88 | 58 |
| 2024-Q2 | Decreased | 96,195 | -70.2% | $45.1M | 0.1% | $468.72 | 0 |